Company / Revenue
CervoMed Inc. Revenue History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$4.0M
FY2025
5-year range
$0 / $7.1M
FY2021-FY2025
Trend
-43.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0 to $4M over the past 2 years.
Based on SEC 10-K filings.
$4M in FY2025.
Improved from $0 to $4M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue decreased 43.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.0M | -43.9% |
| FY2024 | $7.1M | - |
| FY2023 | $0 | -100.0% |
| FY2011 | $570.5K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026